Skip to main content
An official website of the United States government

Alliance of Pancreatic Cancer Consortia (APaCC), and the European Liquid Biopsy Society Workshop on Extracellular Vesicles in Early Detection of Pancreatic Cancer meeting

  • Day 1: Thursday, May 25, 2023 - 8:00am EDT to 2:00pm EDT
  • Day 2: Friday, May 26, 2023 - 8:00am EDT to 12:30pm EDT

May 25, 8 AM-2 PM EDT; 2 PM - 8 PM CET,
May 26, 8 AM – 12:30 PM EDT: 2 PM – 6:30 PM CET,
Times are EDT/Times are CET

May 25:

8:00-8:15 AM EDT
2:00-2:15 PM CET

Opening remarks and charge for the workshop (Sudhir Srivastava, PH.D., M.P.H., National Cancer Institute)

Session 1

  • 8:15-9:45 AM EDT (2:15-3:45 PM CET) - Biology of EVs in Pancreatic Cancer (Chair: David Lyden M.D., Ph.D., Weill Cornell Medical Center)
  • 8:15-8:35 AM - David C. Lyden, M.D., Ph.D., Weill Cornell Medical Center (TBD)
  • 8:35-8:55 AM - Dr. Edit Buzás, M.D., Ph.D., D.Sc., Semmelweis University, (TBD)
  • 8:55-9:15 AM - Catherine Alix-Panabières, PhD, University of Montpellier (CTC and their EVs)
  • 9:15-9:25 AM - Jennifer Jones, M.D., Ph.D. Center for Cancer Research National Cancer Institute (EV Terminology)
  • 9:25-9:45 AM - Discussion Session 1
  • 9:45-9:55 AM - Break

Session 2

  • 9:55-11:45 AM EDT (3:55-5:45 PM CET) - Technology and methods for detecting/analyzing EVs (Chair: Rosalie Sears. Oregon Health & Science University)
  • 9:55-10:15 AM - Rosalie C. Sears, Ph.D., Oregon Health & Science University (TBD)
  • 10:15-10:35 AM - Ralph Weissleder, M.D., Ph.D., Massachusetts General Hospital (Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN)
  • 10:35-10:55 AM - Tijana Jovanovic-Talisman, Ph.D., City of Hope (Biophysical characterization of pancreatic cancer enriched EVs using Single Extracellular VEsicle Nanoscopy)
  • 10:55-11:15 AM - David Issadore, Ph.D., University of Pennsylvania (Microfluidic diagnostic chip Light-activated Proteins and their role in EV packaging)
  • 11:15-11-45 AM - Discussion Session 2
  • 11:45 AM-12:15 PM (5:45-6:15 PM CET) - Keynote: Klaus Pantel, MD, PHD, University Medical Center Hamburg, (EVs in Liquid Biopsy)
  • 12:15-12:30 - Q&A
  • 12:30-12:45 PM - Break

Session 3

  • 12:45-2:15 PM EDT (6:45-8:15 PM CET) - Early-Stage Investigators (Chair: Haiying Zhang)
  • 12:45-1:00 PM ET - Haiying Zhang, Ph.D., Weill Cornell Medical Center (UC modification for EV isolation from Plasma)
  • 1:00-1:15 PM - Stuart Ibsen, Ph.D., Oregon Health & Science University (Use of Dielectrophoresis to Recover Cancer-Derived Extracellular Vesicles from Undiluted Plasma for Pancreatic Cancer Detection)
  • 1:15-1:30 PM  - Yazhen Zhu, M.D., Ph.D., UCLA (Click Chemistry-Mediated Extracellular Vesicle Quantification Assay for Early Detection of Pancreatic Cancer)
  • 1:30-1:45 PM EDT - Jacob Geri, Weill Cornell Medical Center (timsTOF mass spectrometry; interacting proteins on EV surface)
  • 1:45-2:15 PM - Discussion Session 3
  • 2:15 PM EDT (8:15 PM CET) - Adjourn day 1

Day 2, May 26

Session 3

  • 8:00-9:30 AM EDT (2:00-3:30 PM CET) - Consortia and Cohorts (Chair: Michael Goggins, M.B.B.Ch., M.D., The Johns Hopkins)
  • 8:00-8:15 AM EDT - Matthias Loehr, Ph.D., Karolinska Institute (PANCAID consortium)
  • 8:15-8:30 AM - Diane Simeone, M.D., NYU Langone Health Center (PRECEDE: the Pancreatic Cancer Early Detection Consortium)
  • 8:30-8:45 AM - Michael Goggins, M.B.B.Ch., M.D., The Johns Hopkins (Cancer of the Pancreas Screening (CAPS))
  • 9:45-9:00 - Ann Oberg, PH.D., MAYO Clinic, Rochester, (Pancreatic Cancer Detection Consortium (PCDC))
  • 9:00-9:30 AM - Discussion Session 3

Session 4

  • 9:30-11:50 AM EDT (3:30-5:50 PM CET) - Biomarker discovery and validation (Ajay Goel, Ph.D., City of Hope)
  • 9:30-10:00 AM ET - Keynote Juan Pablo (JP) Hinestrosa, Ph.D. VP, Research Biological Dynamics Inc. (Early-stage detection of pancreatic ductal adenocarcinoma (PDAC), EVs in MCED) 
  • 10:00-10:15 - Q&A
  • 10:15-10:30 AM - Break
  • 10:30- 10:50 AM - Daniel W Hagey, Ph.D., Karolinska Institute, Sweden (Dynamic size and association profiles of tumour-derived DNA during pancreatic cancer progression)
  • 10:50-11:10 AM - Ajay Goel, Ph.D., City of Hope (Early Detection of Pancreatic Cancer: Are We Ready for Prime Time?)
  • 11:10-11:20 - Ajay Pratap Singh, Ph.D., University of South Alabama (EV-derived mitochondrial biomarkers for early detection of pancreatic cancer)
  • 11:20-11:50 - Discussion Session 4
  • 11:50 AM-12:30 PM (5:50-6:30 PM CET) - Panel Discussion Meeting Overview
  • 12:30 PM EDT (6:30 PM CET) - Adjourn